FDA GIVES CONDITIONAL APPROVAL TO CANINE LYMPHOMA DRUG

被引:0
作者
Cima, Greg
机构
来源
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION | 2021年 / 258卷 / 05期
关键词
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
引用
收藏
页码:445 / 445
页数:1
相关论文
共 50 条
[31]   FDA: Evidentiary Standards for Drug Development and Approval [J].
Katz R. .
NeuroRX, 2004, 1 (3) :307-316
[32]   The FDA Accelerated Drug Approval Program Explained [J].
不详 .
US PHARMACIST, 2023, 48 (10) :56-57
[33]   SB wins US FDA approval for drug [J].
不详 .
EUROPEAN CHEMICAL NEWS, 1996, 65 (1720) :23-23
[34]   DRUG GROUP ASSESSES FDA APPROVAL PROCESS [J].
EMBER, L .
CHEMICAL & ENGINEERING NEWS, 1990, 68 (04) :6-6
[35]   PhRMA refutes FDA study on drug approval [J].
Barnett, AA .
LANCET, 1996, 347 (8996) :254-254
[36]   ISIS ANTISENSE DRUG WINS FDA APPROVAL [J].
不详 .
CHEMICAL & ENGINEERING NEWS, 2013, 91 (05) :14-14
[37]   FDA unease about faster drug approval [J].
Doshi, Peter .
BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
[39]   FDA gives backing to SB's diabetes drug [J].
不详 .
CHEMISTRY IN BRITAIN, 1999, 35 (06) :10-10
[40]   FDA drug approval summary:: Nelarabine (Arranon®) for the treatment of T-cell lymphoblastic leukemia/lymphoma [J].
Cohen, Martin H. ;
Johnson, John R. ;
Justice, Robert ;
Pazdur, Richard .
ONCOLOGIST, 2008, 13 (06) :709-714